PHX · ASX

PharmX Technologies Limited (ASX:PHX)

AU$0.075

 0.0 (0.0%)
ASX:Live
09/05/2025 01:50:15 PM
HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

PHX Overview

PHX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Neutral

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About PHX

Website

PharmX Technologies Limited

Telephone

61.2.9289.4699

Address

Level 3 120 Sussex Street Sydney, New South Wales (NSW) 2000

Description

PharmX Technologies Ltd. engages in the research and development of software solutions. It operates through the Health Services and eCommerce segment. The Health Services segment provides dispense and point of sale software applications, along with hardware and support services to Australian pharmacies. The eCommerce segment offers individuals and businesses the opportunity to pay their rent, utilities, local government fees, and commercial obligations via electronic methodologies. The company was founded in 1950 and is headquartered in Sydney, Australia.

PHX Price Chart

Key Stats

Market Cap

AU$44.89M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.03 - 0.09

Trade Value (12mth)

AU$8,167.00

1 week

-1.32%

1 month

1.35%

YTD

4.17%

1 year

141.94%

All time high

0.63

Key Fundamentals

EPS 3 yr Growth

-215.00%

EBITDA Margin

23.50%

Operating Cashflow

$3m

Free Cash Flow Return

16.70%

ROIC

0.50%

Interest Coverage

35.40

Quick Ratio

1.40

Other Data

Shares on Issue (Fully Dilluted)

616m

HALO Sector

Technology

Next Company Report Date

01-Sep-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

PHX Announcements

Latest Announcements

Date Announcements

05 May 25

Shareholder Newsletter - May 2025

×

Shareholder Newsletter - May 2025

09 April 25

Notification regarding unquoted securities - PHX

×

Notification regarding unquoted securities - PHX

03 April 25

Pharmx launches new Supplier Portal

×

Pharmx launches new Supplier Portal

26 March 25

Notice of ceasing to be a substantial holder

×

Notice of ceasing to be a substantial holder

26 February 25

Pharmx to present at Coffee Microcap Results Webinar

×

Pharmx to present at Coffee Microcap Results Webinar

19 February 25

H1 FY25 Investor Presentation

×

H1 FY25 Investor Presentation

19 February 25

H1 FY25 Results Announcement

×

H1 FY25 Results Announcement

19 February 25

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

18 February 25

Pharmx announces strategic partnership with Toniq

×

Pharmx announces strategic partnership with Toniq

03 February 25

Notice of Results Announcement

×

Notice of Results Announcement

28 November 24

Change of Company Secretary

×

Change of Company Secretary

26 November 24

Results of Annual General Meeting

×

Results of Annual General Meeting

26 November 24

Chairman's Address & AGM Presentation

×

Chairman's Address & AGM Presentation

21 November 24

Notification of cessation of securities - PHX

×

Notification of cessation of securities - PHX

30 October 24

Investor Presentation

×

Investor Presentation

25 October 24

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

09 September 24

Initial Director's Interest Notice

×

Initial Director's Interest Notice

09 September 24

Alternate Director

×

Alternate Director

03 September 24

Corporate Governance Statement and Appendix 4G

×

Corporate Governance Statement and Appendix 4G

27 August 24

Investor Presentation

×

Investor Presentation

27 August 24

FY24 Results

×

FY24 Results

27 August 24

2024 Annual Report and Appendix 4E

×

2024 Annual Report and Appendix 4E

16 August 24

Delay of Results Announcement

×

Delay of Results Announcement

09 August 24

Update on Fred Appeals in Legal Proceedings

×

Update on Fred Appeals in Legal Proceedings

09 August 24

Letter to Shareholders

×

Letter to Shareholders

PHX Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.00 -0.00 -0.00 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.00 -0.00 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock -80.0 -550.0 -27.8 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.01 0.01 0.00 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.01 0.02 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -6.2 -3.9 -47.0 Lock Lock Lock
     Yield % Lock Lock Lock Lock 15.6 49.1 14.0 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.04 0.04 0.03 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.00 0.01 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -32.0 256.8 -65.7 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 601 597 598 Lock Lock Lock
Basic m Lock Lock Lock Lock 597 597 598 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 5 6 6 Lock Lock Lock
     Growth % Lock Lock Lock Lock -54.5 12.4 7.8 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 2 1 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -30.9 -21.3 18.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock 30.0 21.0 23.1 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 70 79 77 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 2 1 2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -42.9 -18.5 8.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock 32.0 23.2 23.5 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 1 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock -29.1 -53.7 -20.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock 16.3 6.7 4.9 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 0 -1 0 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 0 -1 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -76.9 -517.1 -28.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock 4.7 -17.5 -20.8 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 3 11 3 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 4 3 2 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -4 -4 2 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 0 -5 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 3 11 3 Lock Lock Lock
     Growth % Lock Lock Lock Lock 11.3 240.9 -70.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.6 1.8 0.5 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 6 13 13 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 31 37 30 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -5 -13 -13 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 8 14 14 Lock Lock Lock
Equity $m Lock Lock Lock Lock 23 22 16 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 23 22 16 Lock Lock Lock
     Growth % Lock Lock Lock Lock 1.1 -4.4 -27.5 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 0.8 -2.9 -4.5 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 1.1 -4.7 -8.5 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 3.7 1.8 1.7 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -0.6 -3.9 0.5 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 14.2 48.2 16.7 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock 343.0 25.9 35.4 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -3.2 -9.1 -8.5 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -23.4 -57.5 -80.7 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 1.7 1.8 1.4 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 1.7 1.8 1.4 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 67.1 56.7 80.2 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 64.2 89.0 26.8 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 2.1 2.3 2.3 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 98.7 226.4 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 1.5 0.6 1.5 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 39.5 17.5 27.6 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.2 0.2 0.2 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.2 0.2 0.2 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 0.5 -13.4 0.9 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 0.1 -2.2 0.2 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 -66.7 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 0.8 -2.9 -4.5 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.3 1.6 1.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 1.1 -4.7 -8.5 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 1.1 -4.7 -8.5 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 3.7 1.6 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 171.4 158.9 162.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 175.1 160.5 162.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 255.2 173.6 104.0 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock -80.1 -13.1 58.0 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

PHX Shortsell

Frequently Asked Questions

The current share price of PharmX Technologies Limited (PHX:ASX) is AU$0.075.
The 52-week high share price for PharmX Technologies Limited (PHX:ASX) is AU$0.09.
The 52-week low share price for PharmX Technologies Limited (PHX:ASX)? is AU$0.03.
PharmX Technologies Limited (PHX:ASX) does not pay a dividend.
The last dividend payment of PharmX Technologies Limited (PHX:ASX) is AU$0.01.
PharmX Technologies Limited (PHX:ASX) has a franking level of 0.0%.
PharmX Technologies Limited (PHX:ASX) is classified in the Technology.
The current P/E ratio for PharmX Technologies Limited (PHX:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.